HomeIOVA • NASDAQ
add
Iovance Biotherapeutics Inc
Previous close
$7.17
Day range
$6.24 - $7.03
Year range
$6.24 - $18.33
Market cap
1.95B USD
Avg Volume
6.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 58.56M | 12,385.07% |
Operating expense | 107.80M | -5.85% |
Net income | -83.54M | 26.56% |
Net profit margin | -142.67 | 99.41% |
Earnings per share | -0.28 | 39.13% |
EBITDA | -80.50M | 27.76% |
Effective tax rate | 1.79% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 397.49M | 9.99% |
Total assets | 991.12M | 16.29% |
Total liabilities | 217.66M | 22.07% |
Total equity | 773.46M | — |
Shares outstanding | 304.78M | — |
Price to book | 2.82 | — |
Return on assets | -22.77% | — |
Return on capital | -26.16% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -83.54M | 26.56% |
Cash from operations | -58.97M | 29.86% |
Cash from investing | -48.80M | 38.24% |
Cash from financing | 41.95M | -79.31% |
Net change in cash | -64.57M | -271.22% |
Free cash flow | -22.87M | 50.68% |
About
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
Founded
2007
Headquarters
Website
Employees
557
